Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2007-07-24
2007-07-24
Salimi, Ali R. (Department: 1648)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S235100
Reexamination Certificate
active
10486564
ABSTRACT:
The present invention relates to a method of vaccinating a mammal against papillomavirus by administering papillomavirus virus-like particles transdermally to a mammal under conditions effective to induce an immune response to the papillomavirus.
REFERENCES:
patent: 5057411 (1991-10-01), Lancaster et al.
patent: 5980898 (1999-11-01), Glenn et al.
patent: 6153201 (2000-11-01), Rose et al.
patent: 6165471 (2000-12-01), Garcea et al.
patent: 6228368 (2001-05-01), Gissmann et al.
patent: 6595947 (2003-07-01), Mikszta et al.
patent: 6835184 (2004-12-01), Sage et al.
patent: 1 086 719 (2001-03-01), None
patent: WO 93/02184 (1993-02-01), None
patent: WO 94/00152 (1994-01-01), None
patent: WO 94/05792 (1994-03-01), None
patent: WO 94/20137 (1994-09-01), None
patent: WO 96/11274 (1996-04-01), None
patent: WO 98/02548 (1998-01-01), None
patent: WO 99/43350 (1999-09-01), None
patent: WO 01/34185 (2001-05-01), None
patent: WO 01/66700 (2001-09-01), None
patent: WO 02/085446 (2002-10-01), None
Babiuk et al., “Cutaneous Vaccination: The Skin As An Immunologically Active Tissue and The Challenge of Antigen Delivery,”Journal of Controlled Release66:199-214 (2000).
Gerber et al., “Human Papillomavirus Virus-Like Particles Are Efficient Oral Immunogens when Coadministered withEscherichia coliHeat-Labile Enterotoxin Mutant R192G of CpG DNA,”Journal of Virology75(10):4752-4760 (2001).
Rose et al., “Oral Vaccination of Mice With Human Papillomavirus Virus-Like Particles Induces Systemic Virus-Neutralizing Antibodies,”Vaccine17:2129-2135 (1999).
Glenn et al., “Skin Immunization Made Possible by Cholera Toxin,”Nature391(6670):851 (1998).
Glenn et al., “Transcutaneous Immunization with Bacterial ADP-Ribosylating Exotoxins as Antigens and Adjuvants ,”Inf. Immun.67(3):1100-1106 (1999).
Paul et al., “Transdermal Immunization with Large Proteins by Means of Ultradeformable Drug Carriers,”Eur. J. Immunol.25:3521-3524 (1995).
Scharton-Kersten et al., “Principles of Transcutaneous Immunization Using Cholera Toxin As an Adjuvant,”Vaccine17(Supp. 2):S37-S43 (1999).
Howley, P.M., “The Viruses and Their Replication,”in2 Virology 2045-2076, 2047 (Bernard N. Fields et al. eds., 3d ed. 1995).
Nixon & Peabody LLP
Salimi Ali R.
University of Rochester
LandOfFree
Transcutaneous immunization against papillomavirus with... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Transcutaneous immunization against papillomavirus with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transcutaneous immunization against papillomavirus with... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3754196